Patents Assigned to EGALET US, INC.
  • DEVICE FOR INTRANASAL ADMINISTRATION
    Publication number: 20170173277
    Abstract: Disclosed herein are vials and devices containing a ketorolac solution for intranasal administration and a head space comprising no more than about 10% v/v oxygen and which vials and devices are stored in an oxygen-impermeable pouch. Also disclosed are processes for preparing the vials and devices.
    Type: Application
    Filed: March 3, 2017
    Publication date: June 22, 2017
    Applicant: EGALET US, INC.
    Inventors: Roger Whiting, Ramachandran Thirucote
  • UNIT DOSE FORMULATIONS OF KETOROLAC FOR INTRANASAL ADMINISTRATION
    Publication number: 20160136089
    Abstract: This invention relates to therapeutic compositions, particularly sprayable aqueous compositions, and unit dose formulations comprise ketorolac or a pharmaceutically acceptable salt, alone or in combination with lidocaine or a pharmaceutically acceptable salt thereof. The compositions are nasally administered to a subject in need thereof to treat pain or inflammation.
    Type: Application
    Filed: November 20, 2015
    Publication date: May 19, 2016
    Applicant: EGALET US, INC.
    Inventors: Roger Whiting, Ramachandran Thirucote